Catalyst Wire Dossier Catalyst Wire Dossier

Prazaxa

null · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Prazaxa, covering 2018-01-30 to 2018-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial Fibrillation

See pricing